Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lindeman

Showing results (271-280 of 292) with videos related to

Pageof 30
Sort By:
Ebiomedicine|March 9, 2026
Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classificationCristina Fortuno, Jia Zhang, Lambros T Koufariotis, et al.
Nature Communications|January 25, 2019
Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancerStefano Annunziato, Julian R de Ruiter, Linda Henneman, et al.
Nature Medicine|June 1, 2024
Inhibition of lysine acetyltransferase KAT6 in ER<sup>+</sup>HER2<sup>-</sup> metastatic breast cancer: a phase 1 trialToru Mukohara, Yeon Hee Park, David Sommerhalder, et al.
Gastroenterology|April 21, 2009
Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancerAndrew V Biankin, James G Kench, Emily K Colvin, et al.
Journal of Medical Genetics|June 1, 2005
Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variantsP K Lovelock, S Healey, W Au, et al.
Blood|October 29, 2024
Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemiaMeng-Xiao Luo, Tania Tan, Marie Trussart, et al.
British Journal of Cancer|June 22, 2013
Tumour morphology predicts PALB2 germline mutation statusZ L Teo, E Provenzano, G S Dite, et al.
Stem Cells (Dayton, Ohio)|December 24, 2016
New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem CellsCarmel M O'Brien, Hun S Chy, Qi Zhou, et al.
Plos One|October 23, 2010
The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urineHayley C Whitaker, Zsofia Kote-Jarai, Helen Ross-Adams, et al.
Cancer Metastasis Reviews|December 28, 2016
Patient-derived xenograft (PDX) models in basic and translational breast cancer researchLacey E Dobrolecki, Susie D Airhart, Denis G Alferez, et al.
Pageof 30

Showing results (271-280 of 292) with videos related to

Sort By:
Pageof 30
Ebiomedicine|March 9, 2026
Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classificationCristina Fortuno, Jia Zhang, Lambros T Koufariotis, et al.
Nature Communications|January 25, 2019
Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancerStefano Annunziato, Julian R de Ruiter, Linda Henneman, et al.
Nature Medicine|June 1, 2024
Inhibition of lysine acetyltransferase KAT6 in ER<sup>+</sup>HER2<sup>-</sup> metastatic breast cancer: a phase 1 trialToru Mukohara, Yeon Hee Park, David Sommerhalder, et al.
Gastroenterology|April 21, 2009
Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancerAndrew V Biankin, James G Kench, Emily K Colvin, et al.
Journal of Medical Genetics|June 1, 2005
Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variantsP K Lovelock, S Healey, W Au, et al.
Blood|October 29, 2024
Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemiaMeng-Xiao Luo, Tania Tan, Marie Trussart, et al.
British Journal of Cancer|June 22, 2013
Tumour morphology predicts PALB2 germline mutation statusZ L Teo, E Provenzano, G S Dite, et al.
Stem Cells (Dayton, Ohio)|December 24, 2016
New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem CellsCarmel M O'Brien, Hun S Chy, Qi Zhou, et al.
Plos One|October 23, 2010
The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urineHayley C Whitaker, Zsofia Kote-Jarai, Helen Ross-Adams, et al.
Cancer Metastasis Reviews|December 28, 2016
Patient-derived xenograft (PDX) models in basic and translational breast cancer researchLacey E Dobrolecki, Susie D Airhart, Denis G Alferez, et al.
Pageof 30